Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFKB1
|
ENSG00000109320.7 | nuclear factor kappa B subunit 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFKB1 | hg19_v2_chr4_+_103423055_103423112 | 0.62 | 2.8e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_149792295 | 13.64 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr3_+_63638339 | 10.79 |
ENST00000343837.3
ENST00000469440.1 |
SNTN
|
sentan, cilia apical structure protein |
chr6_-_29527702 | 10.63 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr16_+_67465016 | 8.78 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
chr16_-_66959429 | 8.15 |
ENST00000420652.1
ENST00000299759.6 |
RRAD
|
Ras-related associated with diabetes |
chr5_-_54468974 | 7.21 |
ENST00000381375.2
ENST00000296733.1 ENST00000322374.6 ENST00000334206.5 ENST00000331730.3 |
CDC20B
|
cell division cycle 20B |
chr9_+_127615733 | 6.68 |
ENST00000373574.1
|
WDR38
|
WD repeat domain 38 |
chr19_+_45504688 | 5.09 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr6_+_135502466 | 4.87 |
ENST00000367814.4
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr6_+_32605195 | 4.85 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr10_+_12391481 | 4.64 |
ENST00000378847.3
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID |
chr17_+_40440481 | 4.55 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr6_-_109762344 | 4.34 |
ENST00000521072.2
ENST00000424445.2 ENST00000440797.2 |
PPIL6
|
peptidylprolyl isomerase (cyclophilin)-like 6 |
chr6_+_32821924 | 3.68 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr1_+_6845497 | 3.67 |
ENST00000473578.1
ENST00000557126.1 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr14_+_75536335 | 3.40 |
ENST00000554763.1
ENST00000439583.2 ENST00000526130.1 ENST00000525046.1 |
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
chr19_+_10527449 | 3.35 |
ENST00000592685.1
ENST00000380702.2 |
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr4_+_74735102 | 3.30 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr14_+_75536280 | 3.24 |
ENST00000238686.8
|
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
chr6_+_32605134 | 3.03 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr10_+_12391685 | 2.99 |
ENST00000378845.1
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID |
chr10_-_102089729 | 2.77 |
ENST00000465680.2
|
PKD2L1
|
polycystic kidney disease 2-like 1 |
chr6_+_29691198 | 2.73 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr6_+_29691056 | 2.73 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr15_+_76352178 | 2.72 |
ENST00000388942.3
|
C15orf27
|
chromosome 15 open reading frame 27 |
chr1_+_6845578 | 2.64 |
ENST00000467404.2
ENST00000439411.2 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr17_+_7590734 | 2.63 |
ENST00000457584.2
|
WRAP53
|
WD repeat containing, antisense to TP53 |
chrX_-_112084043 | 2.62 |
ENST00000304758.1
|
AMOT
|
angiomotin |
chr2_-_217560248 | 2.59 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr1_+_54359854 | 2.58 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
chr2_+_38893208 | 2.58 |
ENST00000410063.1
|
GALM
|
galactose mutarotase (aldose 1-epimerase) |
chr8_+_104831554 | 2.44 |
ENST00000408894.2
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
chr16_+_50775948 | 2.37 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr14_+_75988768 | 2.34 |
ENST00000286639.6
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr12_+_52445191 | 2.30 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr6_-_111804905 | 2.26 |
ENST00000358835.3
ENST00000435970.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
chr1_+_6845384 | 2.23 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr1_+_100818156 | 2.16 |
ENST00000336454.3
|
CDC14A
|
cell division cycle 14A |
chr16_-_53737795 | 2.10 |
ENST00000262135.4
ENST00000564374.1 ENST00000566096.1 |
RPGRIP1L
|
RPGRIP1-like |
chr16_-_53737722 | 2.09 |
ENST00000569716.1
ENST00000562588.1 ENST00000562230.1 ENST00000379925.3 ENST00000563746.1 ENST00000568653.3 |
RPGRIP1L
|
RPGRIP1-like |
chr1_+_201979645 | 2.01 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr8_+_86157699 | 1.93 |
ENST00000321764.3
|
CA13
|
carbonic anhydrase XIII |
chr5_-_55290773 | 1.92 |
ENST00000502326.3
ENST00000381298.2 |
IL6ST
|
interleukin 6 signal transducer (gp130, oncostatin M receptor) |
chr14_-_61190754 | 1.92 |
ENST00000216513.4
|
SIX4
|
SIX homeobox 4 |
chr6_+_29910301 | 1.87 |
ENST00000376809.5
ENST00000376802.2 |
HLA-A
|
major histocompatibility complex, class I, A |
chr16_+_50775971 | 1.86 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr16_+_57126482 | 1.85 |
ENST00000537605.1
ENST00000535318.2 |
CPNE2
|
copine II |
chr17_-_56065484 | 1.78 |
ENST00000581208.1
|
VEZF1
|
vascular endothelial zinc finger 1 |
chr11_-_75062829 | 1.78 |
ENST00000393505.4
|
ARRB1
|
arrestin, beta 1 |
chr2_-_157189180 | 1.76 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr16_+_57126428 | 1.73 |
ENST00000290776.8
|
CPNE2
|
copine II |
chr2_+_97203082 | 1.71 |
ENST00000454558.2
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like) |
chr7_+_69064300 | 1.63 |
ENST00000342771.4
|
AUTS2
|
autism susceptibility candidate 2 |
chr20_-_62462566 | 1.63 |
ENST00000245663.4
ENST00000302995.2 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
chr4_-_74904398 | 1.62 |
ENST00000296026.4
|
CXCL3
|
chemokine (C-X-C motif) ligand 3 |
chr17_+_8924837 | 1.61 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
chr6_+_138188551 | 1.60 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr14_+_75988851 | 1.60 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr7_-_127032363 | 1.59 |
ENST00000393312.1
|
ZNF800
|
zinc finger protein 800 |
chr2_+_97202480 | 1.56 |
ENST00000357485.3
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like) |
chr11_+_102188272 | 1.52 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr6_+_80341000 | 1.51 |
ENST00000369838.4
|
SH3BGRL2
|
SH3 domain binding glutamic acid-rich protein like 2 |
chr6_+_18155632 | 1.49 |
ENST00000297792.5
|
KDM1B
|
lysine (K)-specific demethylase 1B |
chr20_+_44746885 | 1.47 |
ENST00000372285.3
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5 |
chr1_+_89990431 | 1.44 |
ENST00000330947.2
ENST00000358200.4 |
LRRC8B
|
leucine rich repeat containing 8 family, member B |
chr14_-_35873856 | 1.40 |
ENST00000553342.1
ENST00000216797.5 ENST00000557140.1 |
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
chr2_-_211036051 | 1.40 |
ENST00000418791.1
ENST00000452086.1 ENST00000281772.9 |
KANSL1L
|
KAT8 regulatory NSL complex subunit 1-like |
chr19_-_47734448 | 1.34 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr11_+_63997750 | 1.34 |
ENST00000321685.3
|
DNAJC4
|
DnaJ (Hsp40) homolog, subfamily C, member 4 |
chr4_-_74964904 | 1.33 |
ENST00000508487.2
|
CXCL2
|
chemokine (C-X-C motif) ligand 2 |
chr6_+_149068464 | 1.31 |
ENST00000367463.4
|
UST
|
uronyl-2-sulfotransferase |
chr11_+_65292884 | 1.30 |
ENST00000527009.1
|
SCYL1
|
SCY1-like 1 (S. cerevisiae) |
chr11_-_75062730 | 1.29 |
ENST00000420843.2
ENST00000360025.3 |
ARRB1
|
arrestin, beta 1 |
chr9_+_17579084 | 1.29 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
chr19_-_49149553 | 1.26 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
chr11_-_96076334 | 1.26 |
ENST00000524717.1
|
MAML2
|
mastermind-like 2 (Drosophila) |
chr11_-_72853091 | 1.25 |
ENST00000311172.7
ENST00000409314.1 |
FCHSD2
|
FCH and double SH3 domains 2 |
chr15_-_27018884 | 1.24 |
ENST00000299267.4
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
chr20_-_50159198 | 1.24 |
ENST00000371564.3
ENST00000396009.3 ENST00000610033.1 |
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
chr1_+_211432593 | 1.23 |
ENST00000367006.4
|
RCOR3
|
REST corepressor 3 |
chr5_+_56469843 | 1.22 |
ENST00000514387.2
|
GPBP1
|
GC-rich promoter binding protein 1 |
chr16_+_50776021 | 1.20 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr11_+_72525353 | 1.18 |
ENST00000321297.5
ENST00000534905.1 ENST00000540567.1 |
ATG16L2
|
autophagy related 16-like 2 (S. cerevisiae) |
chr19_+_2476116 | 1.18 |
ENST00000215631.4
ENST00000587345.1 |
GADD45B
|
growth arrest and DNA-damage-inducible, beta |
chr1_+_183441500 | 1.17 |
ENST00000456731.2
|
SMG7
|
SMG7 nonsense mediated mRNA decay factor |
chr6_-_17706618 | 1.15 |
ENST00000262077.2
ENST00000537253.1 |
NUP153
|
nucleoporin 153kDa |
chr1_+_100818009 | 1.15 |
ENST00000370125.2
ENST00000361544.6 ENST00000370124.3 |
CDC14A
|
cell division cycle 14A |
chr2_+_54951679 | 1.15 |
ENST00000356458.6
|
EML6
|
echinoderm microtubule associated protein like 6 |
chr4_+_103422471 | 1.14 |
ENST00000226574.4
ENST00000394820.4 |
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr22_-_38349552 | 1.14 |
ENST00000422191.1
ENST00000249079.2 ENST00000418863.1 ENST00000403305.1 ENST00000403026.1 |
C22orf23
|
chromosome 22 open reading frame 23 |
chr1_+_18434240 | 1.13 |
ENST00000251296.1
|
IGSF21
|
immunoglobin superfamily, member 21 |
chr14_-_24616426 | 1.10 |
ENST00000216802.5
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr12_-_46121554 | 1.10 |
ENST00000609803.1
|
LINC00938
|
long intergenic non-protein coding RNA 938 |
chr12_-_55375622 | 1.10 |
ENST00000316577.8
|
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr11_+_65292538 | 1.09 |
ENST00000270176.5
ENST00000525364.1 ENST00000420247.2 ENST00000533862.1 ENST00000279270.6 ENST00000524944.1 |
SCYL1
|
SCY1-like 1 (S. cerevisiae) |
chr6_-_44233361 | 1.08 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr17_-_7590745 | 1.07 |
ENST00000514944.1
ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53
|
tumor protein p53 |
chr19_+_35940486 | 1.05 |
ENST00000246549.2
|
FFAR2
|
free fatty acid receptor 2 |
chr2_+_208394616 | 1.05 |
ENST00000432329.2
ENST00000353267.3 ENST00000445803.1 |
CREB1
|
cAMP responsive element binding protein 1 |
chr1_+_38259540 | 1.03 |
ENST00000397631.3
|
MANEAL
|
mannosidase, endo-alpha-like |
chr1_+_27114418 | 1.03 |
ENST00000078527.4
|
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr4_-_140098339 | 1.01 |
ENST00000394235.2
|
ELF2
|
E74-like factor 2 (ets domain transcription factor) |
chr19_-_33555780 | 0.99 |
ENST00000254260.3
ENST00000400226.4 |
RHPN2
|
rhophilin, Rho GTPase binding protein 2 |
chr2_+_208394794 | 0.99 |
ENST00000536726.1
ENST00000374397.4 ENST00000452474.1 |
CREB1
|
cAMP responsive element binding protein 1 |
chr19_+_55795493 | 0.99 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr5_+_56469775 | 0.99 |
ENST00000424459.3
|
GPBP1
|
GC-rich promoter binding protein 1 |
chr11_+_34642656 | 0.98 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr2_+_42721689 | 0.96 |
ENST00000405592.1
|
MTA3
|
metastasis associated 1 family, member 3 |
chr1_+_38259459 | 0.96 |
ENST00000373045.6
|
MANEAL
|
mannosidase, endo-alpha-like |
chr13_-_30424821 | 0.95 |
ENST00000380680.4
|
UBL3
|
ubiquitin-like 3 |
chr19_-_4338783 | 0.95 |
ENST00000601482.1
ENST00000600324.1 |
STAP2
|
signal transducing adaptor family member 2 |
chr17_-_7123021 | 0.94 |
ENST00000399510.2
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr11_-_77185094 | 0.93 |
ENST00000278568.4
ENST00000356341.3 |
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1 |
chr5_-_135231516 | 0.89 |
ENST00000274520.1
|
IL9
|
interleukin 9 |
chr7_+_17338239 | 0.88 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
chr19_-_4338838 | 0.88 |
ENST00000594605.1
|
STAP2
|
signal transducing adaptor family member 2 |
chr2_+_32853093 | 0.88 |
ENST00000448773.1
ENST00000317907.4 |
TTC27
|
tetratricopeptide repeat domain 27 |
chr20_+_44746939 | 0.86 |
ENST00000372276.3
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5 |
chr1_+_27561007 | 0.86 |
ENST00000319394.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
chr2_-_152955537 | 0.84 |
ENST00000201943.5
ENST00000539935.1 |
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
chr9_-_124990680 | 0.82 |
ENST00000541397.2
ENST00000560485.1 |
LHX6
|
LIM homeobox 6 |
chr5_+_56469939 | 0.82 |
ENST00000506184.2
|
GPBP1
|
GC-rich promoter binding protein 1 |
chr15_+_44719970 | 0.81 |
ENST00000558966.1
|
CTDSPL2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
chr1_-_151299842 | 0.80 |
ENST00000438243.2
ENST00000489223.2 ENST00000368873.1 ENST00000430800.1 ENST00000368872.1 |
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta |
chr10_-_73533255 | 0.80 |
ENST00000394957.3
|
C10orf54
|
chromosome 10 open reading frame 54 |
chr6_+_30850697 | 0.80 |
ENST00000509639.1
ENST00000412274.2 ENST00000507901.1 ENST00000507046.1 ENST00000437124.2 ENST00000454612.2 ENST00000396342.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr17_+_4634705 | 0.80 |
ENST00000575284.1
ENST00000573708.1 ENST00000293777.5 |
MED11
|
mediator complex subunit 11 |
chr17_-_7197881 | 0.79 |
ENST00000007699.5
|
YBX2
|
Y box binding protein 2 |
chr2_+_38893047 | 0.79 |
ENST00000272252.5
|
GALM
|
galactose mutarotase (aldose 1-epimerase) |
chr4_-_122085469 | 0.79 |
ENST00000057513.3
|
TNIP3
|
TNFAIP3 interacting protein 3 |
chrX_+_40440146 | 0.78 |
ENST00000535539.1
ENST00000378438.4 ENST00000436783.1 ENST00000544975.1 ENST00000535777.1 ENST00000447485.1 ENST00000423649.1 |
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2 |
chr2_+_61108771 | 0.78 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr9_+_82188077 | 0.77 |
ENST00000425506.1
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr11_-_46142505 | 0.76 |
ENST00000524497.1
ENST00000418153.2 |
PHF21A
|
PHD finger protein 21A |
chr1_+_156123318 | 0.76 |
ENST00000368285.3
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr11_-_47400062 | 0.76 |
ENST00000533030.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr6_-_30080876 | 0.75 |
ENST00000376734.3
|
TRIM31
|
tripartite motif containing 31 |
chr1_+_63833261 | 0.74 |
ENST00000371108.4
|
ALG6
|
ALG6, alpha-1,3-glucosyltransferase |
chr1_+_156123359 | 0.74 |
ENST00000368284.1
ENST00000368286.2 ENST00000438830.1 |
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr11_+_113930291 | 0.73 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr2_+_208394455 | 0.73 |
ENST00000430624.1
|
CREB1
|
cAMP responsive element binding protein 1 |
chr1_+_110453109 | 0.72 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr5_-_96143796 | 0.72 |
ENST00000296754.3
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr12_+_11802753 | 0.69 |
ENST00000396373.4
|
ETV6
|
ets variant 6 |
chr12_+_7052974 | 0.68 |
ENST00000544681.1
ENST00000537087.1 |
C12orf57
|
chromosome 12 open reading frame 57 |
chr8_-_103668114 | 0.68 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
chr5_-_127418755 | 0.66 |
ENST00000501702.2
ENST00000501173.2 ENST00000514573.1 ENST00000499346.2 ENST00000606251.1 |
CTC-228N24.3
|
CTC-228N24.3 |
chr2_+_163175394 | 0.66 |
ENST00000446271.1
ENST00000429691.2 |
GCA
|
grancalcin, EF-hand calcium binding protein |
chr1_+_27561104 | 0.66 |
ENST00000361771.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
chr11_-_47399942 | 0.65 |
ENST00000227163.4
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr15_+_89346657 | 0.65 |
ENST00000439576.2
|
ACAN
|
aggrecan |
chr6_-_27279949 | 0.65 |
ENST00000444565.1
ENST00000377451.2 |
POM121L2
|
POM121 transmembrane nucleoporin-like 2 |
chr15_-_77712477 | 0.65 |
ENST00000560626.2
|
PEAK1
|
pseudopodium-enriched atypical kinase 1 |
chr11_-_46142615 | 0.65 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
chr11_+_560956 | 0.65 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr13_+_97874574 | 0.64 |
ENST00000343600.4
ENST00000345429.6 ENST00000376673.3 |
MBNL2
|
muscleblind-like splicing regulator 2 |
chr1_+_169077172 | 0.64 |
ENST00000499679.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr14_+_24616588 | 0.64 |
ENST00000324103.6
ENST00000559260.1 |
RNF31
|
ring finger protein 31 |
chr3_+_53195136 | 0.64 |
ENST00000394729.2
ENST00000330452.3 |
PRKCD
|
protein kinase C, delta |
chr3_-_187455680 | 0.62 |
ENST00000438077.1
|
BCL6
|
B-cell CLL/lymphoma 6 |
chr15_-_89438742 | 0.62 |
ENST00000562281.1
ENST00000562889.1 ENST00000359595.3 |
HAPLN3
|
hyaluronan and proteoglycan link protein 3 |
chr4_-_103748880 | 0.62 |
ENST00000453744.2
ENST00000349311.8 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr12_+_7053228 | 0.62 |
ENST00000540506.2
|
C12orf57
|
chromosome 12 open reading frame 57 |
chr11_-_47400078 | 0.62 |
ENST00000378538.3
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr13_+_108922228 | 0.61 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
chr2_+_61108650 | 0.61 |
ENST00000295025.8
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr6_+_88299833 | 0.60 |
ENST00000392844.3
ENST00000257789.4 ENST00000546266.1 ENST00000417380.2 |
ORC3
|
origin recognition complex, subunit 3 |
chr11_+_118307179 | 0.60 |
ENST00000534358.1
ENST00000531904.2 ENST00000389506.5 ENST00000354520.4 |
KMT2A
|
lysine (K)-specific methyltransferase 2A |
chr3_-_50605150 | 0.59 |
ENST00000357203.3
|
C3orf18
|
chromosome 3 open reading frame 18 |
chr6_+_33168637 | 0.59 |
ENST00000374677.3
|
SLC39A7
|
solute carrier family 39 (zinc transporter), member 7 |
chr5_+_139781445 | 0.56 |
ENST00000532219.1
ENST00000394722.3 |
ANKHD1-EIF4EBP3
ANKHD1
|
ANKHD1-EIF4EBP3 readthrough ankyrin repeat and KH domain containing 1 |
chr15_+_85923797 | 0.56 |
ENST00000559362.1
|
AKAP13
|
A kinase (PRKA) anchor protein 13 |
chr12_+_7053172 | 0.56 |
ENST00000229281.5
|
C12orf57
|
chromosome 12 open reading frame 57 |
chr6_+_33168597 | 0.55 |
ENST00000374675.3
|
SLC39A7
|
solute carrier family 39 (zinc transporter), member 7 |
chr7_+_101460882 | 0.55 |
ENST00000292535.7
ENST00000549414.2 ENST00000550008.2 ENST00000546411.2 ENST00000556210.1 |
CUX1
|
cut-like homeobox 1 |
chr3_+_9691117 | 0.55 |
ENST00000353332.5
ENST00000420925.1 ENST00000296003.4 ENST00000351233.5 |
MTMR14
|
myotubularin related protein 14 |
chr3_-_50605077 | 0.54 |
ENST00000426034.1
ENST00000441239.1 |
C3orf18
|
chromosome 3 open reading frame 18 |
chr1_-_8000872 | 0.53 |
ENST00000377507.3
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
chr3_+_197518100 | 0.52 |
ENST00000438796.2
ENST00000414675.2 ENST00000441090.2 ENST00000334859.4 ENST00000425562.2 |
LRCH3
|
leucine-rich repeats and calponin homology (CH) domain containing 3 |
chr6_-_74230741 | 0.51 |
ENST00000316292.9
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr2_+_208394658 | 0.50 |
ENST00000421139.1
|
CREB1
|
cAMP responsive element binding protein 1 |
chr6_+_33378738 | 0.50 |
ENST00000374512.3
ENST00000374516.3 |
PHF1
|
PHD finger protein 1 |
chr17_+_63133587 | 0.49 |
ENST00000449996.3
ENST00000262406.9 |
RGS9
|
regulator of G-protein signaling 9 |
chr1_+_183441618 | 0.49 |
ENST00000507691.2
ENST00000508461.1 ENST00000419169.1 ENST00000347615.2 ENST00000507469.1 ENST00000515829.2 |
SMG7
|
SMG7 nonsense mediated mRNA decay factor |
chr11_-_65363259 | 0.49 |
ENST00000342202.4
|
KCNK7
|
potassium channel, subfamily K, member 7 |
chr4_-_185395672 | 0.49 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
chr12_-_24103954 | 0.48 |
ENST00000441133.2
ENST00000545921.1 |
SOX5
|
SRY (sex determining region Y)-box 5 |
chr13_+_39261224 | 0.48 |
ENST00000280481.7
|
FREM2
|
FRAS1 related extracellular matrix protein 2 |
chr1_+_183441600 | 0.47 |
ENST00000367537.3
|
SMG7
|
SMG7 nonsense mediated mRNA decay factor |
chrX_+_130192318 | 0.47 |
ENST00000370922.1
|
ARHGAP36
|
Rho GTPase activating protein 36 |
chr1_+_100818484 | 0.47 |
ENST00000544534.1
|
CDC14A
|
cell division cycle 14A |
chr5_+_54603566 | 0.46 |
ENST00000230640.5
|
SKIV2L2
|
superkiller viralicidic activity 2-like 2 (S. cerevisiae) |
chr17_+_21191341 | 0.46 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr15_-_71055878 | 0.45 |
ENST00000322954.6
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr16_+_67282853 | 0.45 |
ENST00000299798.11
|
SLC9A5
|
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
chr3_+_49058444 | 0.44 |
ENST00000326925.6
ENST00000395458.2 |
NDUFAF3
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 |
chr11_-_133826852 | 0.44 |
ENST00000533871.2
ENST00000321016.8 |
IGSF9B
|
immunoglobulin superfamily, member 9B |
chr9_-_117568365 | 0.44 |
ENST00000374045.4
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15 |
chr5_+_139781393 | 0.42 |
ENST00000360839.2
ENST00000297183.6 ENST00000421134.1 ENST00000394723.3 ENST00000511151.1 |
ANKHD1
|
ankyrin repeat and KH domain containing 1 |
chr1_-_44818599 | 0.42 |
ENST00000537474.1
|
ERI3
|
ERI1 exoribonuclease family member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.1 | 10.6 | GO:0070842 | aggresome assembly(GO:0070842) |
2.0 | 8.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.8 | 5.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.6 | 4.9 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.1 | 4.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.9 | 2.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.9 | 2.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.8 | 3.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.8 | 7.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.7 | 6.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 1.9 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.6 | 1.8 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
0.6 | 1.8 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 3.3 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.5 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 8.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.5 | 2.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.5 | 1.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.4 | 3.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.4 | 1.2 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.4 | 1.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 6.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 1.1 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 1.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 2.3 | GO:0033590 | response to cobalamin(GO:0033590) |
0.3 | 2.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 1.2 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.3 | 0.9 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 0.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 1.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 3.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 1.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 1.9 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.3 | 2.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 0.7 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 3.8 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.2 | 1.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 0.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.2 | 1.9 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.2 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 1.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.6 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.2 | 4.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.8 | GO:0009386 | translational attenuation(GO:0009386) |
0.2 | 1.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 1.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 2.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 1.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.6 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 0.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 2.6 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 3.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.1 | 0.6 | GO:1903281 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 9.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.6 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 1.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.8 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 2.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 2.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 1.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 11.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.7 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 4.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 3.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.1 | 7.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.9 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.2 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 1.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.0 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.0 | 1.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 3.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 1.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 1.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 2.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.3 | GO:0061734 | negative regulation of receptor recycling(GO:0001920) parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 1.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.0 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 1.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 1.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 2.5 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.0 | 1.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 1.8 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.3 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.0 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.5 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 1.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 1.0 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 13.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.8 | 4.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 8.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 7.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 1.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 3.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.4 | 3.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 7.9 | GO:0042611 | MHC protein complex(GO:0042611) MHC class II protein complex(GO:0042613) |
0.4 | 2.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.3 | 4.0 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 2.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 2.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 1.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 0.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.2 | 2.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 10.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 2.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 4.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 5.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 3.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 3.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 6.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 3.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 1.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 1.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 1.5 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 10.8 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 2.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
2.7 | 13.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.4 | 4.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
1.0 | 3.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.9 | 7.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 5.2 | GO:0046979 | TAP2 binding(GO:0046979) |
0.6 | 1.9 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) leukemia inhibitory factor receptor activity(GO:0004923) interleukin-6 binding(GO:0019981) |
0.6 | 7.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.5 | 10.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 7.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.4 | 2.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.4 | 2.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 3.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.4 | 4.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 0.9 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 1.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.2 | 1.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 1.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 1.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 3.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 3.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 2.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 5.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 1.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 3.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 3.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 4.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 6.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 1.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 3.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 3.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 4.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 2.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 3.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 2.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 1.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 1.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 17.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.0 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 5.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 6.2 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 1.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 1.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.9 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 11.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 5.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 8.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 5.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 8.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 3.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 5.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 7.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 2.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 3.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 8.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 3.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 5.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 2.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 3.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 12.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 4.5 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 5.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 2.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |